President Donald Trump has endorsed a new drug treatment for bipolar depression that he says is “truly effective.”

The drug, called naltrexone, can help treat bipolar disorder and anxiety disorders.

The drug is being tested in two clinical trials in Colorado and New Mexico.

The U.S. Centers for Disease Control and Prevention says the drug is also used for opioid addiction and depression.

The U.K. government is also testing the drug.

Trump announced on Twitter the news Wednesday, calling the drug “tremendous.”

The president also said the drug’s manufacturer, Merck, will be “honored to continue manufacturing and distributing Naltrexa.”

“It works, it’s effective, it is very inexpensive and the results are so impressive,” Trump said.

“It’s a fantastic drug.”

The pharmaceutical company that manufactures the drug, Sanofi, confirmed that it will “continue to invest in and deliver NaltraXa to patients, health care providers and the public.”

Sanofi, which also makes the drug for other illnesses, said it would work with the White House to expand the availability of the drug and continue to make it available to more people.

The president is the latest in a series of U.A.E. leaders to support a drug for bipolar mood disorder that was approved by the Food and Drug Administration.

Last month, President Rodrigo Duterte of the Philippines approved a similar drug.

The new drug is a first in a new class of anti-depressants called lithium-sulfate, which is also known as lithium, lithium-air, lithium plus or lithium-proton.

It was approved in 2018 and will be on the market for the first time in 2021.

The FDA approved lithium sulfate in 2016.

The drug’s maker, Valeant Pharmaceuticals, said last year that it was working with the FDA to expand its availability.

The company said lithium sulfates are a cost-effective and safe alternative to lithium for people who have mood disorders.